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SUMMARY 
Gastric cancer (GC) is one of the most leading cause of cancer death. The 
high mortality is due to late diagnosis, although the gastric infection by 
Helicobacter pylori represents one of the most significant risk factors for 
this type of cancer. Gastrokine-1 (GKN1) is expressed in normal gastric 
tissue, while it is scarcely present in samples from patients infected by H. 
pylori, and completely absent in GC tissues and cell lines. Therefore, 
GKN1 could be a potential marker for GC diagnosis and a possible tumor 
suppressor. In order to get more insights into the molecular mechanisms 
on the pathology of GC, this study was directed to better understand the 
structural features and the biological activity of this protein. In details, 
this study was directed to: 1) synthesis of recombinant mature GKN1 by 
cloning, expression and purification; 2) characterization of structural and 
biochemical properties of recombinant GKN1 by circular dichroism, 
fluorescence spectroscopy, and limited proteolysis; 3) evaluation of the 
effect of recombinant GKN1 on gastric cancer cell lines growth; 4) 
construction of a 3D structural model of the protein. The first protocol for 
biosynthesis and purification of native human GKN1 in the homologous 
expression system of Pichia pastoris was settled. The use of biochemical 
analytical methods such as limited proteolysis led to the identification of 
exposed amino acid residues on the protein surface. The resistance of 
GKN1 to the action of proteolytic enzymes was somehow explanatory of 
its stability in the harsh stomach environment. Spectroscopic studies 
(fluorescence and circular dichroism) showed that the protein is endowed 
by a non-proper globular structure due probably to the presence of two 
domains. These domains showed a different behaviour toward chemical 
and physical denaturant. The results well correlate with predicted GKN1 
secondary structure and 3D structure model. Finally, the recombinant 
protein showed anti-proliferative properties on gastric cancer cell lines. 
Our findings contribute to a preliminary clarification of the role of GKN1 
in the pathogenesis of gastric cancer. 
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RIASSUNTO 
Il carcinoma gastrico (GC) è una delle principali cause di morte per 
cancro. L'elevata mortalità è dovuta ad una diagnosi tardiva, anche se 
l'infezione da Helicobacter pylori (H. pylori) rappresenta uno dei fattori di 
rischio più significativi. La Gastrokine-1 (GKN1) è espressa nel tessuto 
gastrico normale , mentre è scarsamente presente nei pazienti con 
infezione da H. pylori, ed è completamente assente in tessuti di pazienti 
affetti da GC. Pertanto, GKN1 potrebbe rappresentare un potenziale 
“marker” per l’ individuazione in fase precoce della malattia ed un 
possibile farmaco soppressore tumorale. Allo scopo di ottenere 
informazioni preliminari sui meccanismi molecolari alla base del GC, 
questo lavoro di tesi è rivolto alla comprensione delle caratteristiche 
strutturali e funzionali della GKN1. 
Nel dettaglio, questo studio è stato sviluppato come di seguito riportato: 1) 
sintesi ricombinante di GKN1 mediante clonaggio, espressione e 
purificazione; 2) caratterizzazione delle proprietà strutturali e biochimiche 
di GKN1 ricombinante attraverso studi di dicroismo circolare, 
fluorescenza e proteolisi limitata; 3) valutazione dell’effetto di GKN1 
ricombinante sulla vitalità di linee cellulari di cancro gastrico 4) 
costruzione di un modello strutturale 3D della proteina. Il protocollo 
impiegato per la biosintesi e la purificazione di GKN1 umana si basa 
sull’utilizzo del sistema di espressione eucariotico di lievito Pichia 
pastoris (P. pastoris). L'utilizzo di metodi biochimici analitici come la 
proteolisi limitata ha portato all'individuazione di residui di aminoacidi 
esposti sulla superficie della proteina. La resistenza di GKN1 all'azione di 
enzimi proteolitici è, in qualche modo, esplicativa della sua stabilità 
nell’ambiente gastrico. Studi spettroscopici di fluorescenza e di dicroismo 
circolare hanno dimostrato che la proteina non ha una struttura globulare 
compatta, ma sembra caratterizzata dalla presenza di due domini. Questi 
domini presentano un diverso comportamento chimico e fisico verso gli 
agenti denaturanti. I dati ottenuti risultano coerenti con le informazioni di 
struttura secondaria predetti per GKN1 e con il modello 3D. Infine, la 
proteina ricombinante ha mostrato proprietà anti-proliferative su linee 
cellulari di cancro gastrico. I nostri risultati contribuiscono al chiarimento 
preliminare del ruolo del GKN1 nella patogenesi del cancro gastrico.
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INTRODUCTION 
1.1 Gastric cancer 
Gastric cancer (GC) is one of the most common solid tumor in the world. 
High incidence rates are found in Japan, in some regions of East Asia and 
in some Latin American countries (1-2), but the rates of mortality and 
incidence of the disease are very high also in Europe. Despite advances in 
conventional therapies, the survival rate of patients with GC up to 5 years 
is poor (<30%), thus GC resulting the third leading cause of death after 
lung, colorectal and breast cancer (3). The incidence of GC is often 
related to advancing age: in particular, the tumor occurs on average 
between 45 and 55 years and affects males twice than females. 
The aetiology of GC is multi-factorial including environmental, genetic 
and infectious factors (2, 4-6). A prominent role is played by 
environmental factors such as smoking and alcohol abuse, presence of 
carcinogen agents in some foods, a diet rich of fat, smoked or salted foods 
and missing of fruits and vegetables, and finally, exposure to carcinogenic 
environmental contaminants (4). The influence of genetic factors in 
gastric carcinogenesis has been documented by studies where the 
occurrence of more than one case of GC in the same family is associated 
to a genetic predisposition due to alteration in the tumor suppressor genes 
p53 and APC (adenomatous polypis coli) which are involved in the 
malignant transformation of various organs (5). Multiple evidence 
demonstrated the important role of Helicobacter pylori (H. pylori) 
infection in the development of GC (6-8). H. pylori is a parasite of the 
gastric mucosa and induces a complex inflammatory reaction 
characterized by the release of inflammatory cytokines and production 
Reactive Oxygen Species (ROS) (6). These factors created to fight the 
infection of H. pylori also damage the cells of the stomach when they do 
not possess sufficient reserves of natural antioxidants such as vitamin C 
or vitamin E. Thus, most of H. pylori infected subjects develop acute 
gastritis, which, if not properly treated, causes chronic disease, and 
evolves in ulcer or tumor (9). 
In two-thirds of patients in western countries, GC is diagnosed in an 
advanced stage, and because this type of tumor is resistant to radiotherapy 
and chemotherapy, surgery represents the only curative treatment, 
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although often it is only a temporary solution (10). Currently, therefore, 
there is an urgent need to clarify the molecular mechanisms underlying 
the processes of transformation and neoplastic progression, to identify 
new prognostic parameters and to develop more effective therapies for 
GC. 
Recently, the tissue-specific protein gastrokine-1 (GKN1) has emerged as 
a possible biomarkers for GC (11-12). This protein expressed in the 
human stomach of healthy individuals, is absent in gastric 
adenocarcinoma tissues, and in other tissues such as placenta and ovaries 
(13-15). However, GKN1 might also be present at low levels in normal 
uterus, liver, kidney, pancreas and adrenal and salivary glands (12). Some 
evidence suggests that GKN1 is involved in filling the lumen of the 
surface layer of epithelial cells to maintain the integrity of the mucosa and 
to regulate cell proliferation and differentiation (12-13). As result of the 
damage to the gastric mucosa, the presence of GKN1 helps to restore the 
normal state of the mucosa (14). On the contrary, if the protein is not 
expressed, the repair process is impeded. Addition of GKN1, in fact, 
promotes restoring of damaged epithelium in gastrointestinal cells (16). It 
has been also demonstrated that GKN1 expression induces apoptosis in 
GC cells, demonstrating the importance of GKN1 in inhibiting the 
development of GC (17). Individuals with a lower expression of the 
protein have an increased risk to develop gastric diseases (18). The 
protein is, in fact, not expressed in samples from patients infected with H. 
pylori and is completely absent in tissues of GC (11-12, 14-15). 
 
1.2 Gastrokine-1 
Gastrokine-1 protein, previously known as 18 kDa antrum mucosal 
protein (AMP-18) was subsequently called by '"Human Gene 
Nomenclature Committee" GKN1 for its tissue-specific expression and its 
highly conserved presence in the gastric mucosa of many mammals 
species (12-13). The gene coding for GKN1 (CA11) (accession number: 
BK0017373), is located on chromosome 2 (19). Sequence analysis of the 
gene showed that the human transcript contains two potential translation 
start sites (ATG). The first start codon would generate a protein of 199 
amino acids whereas the second ATG, located 42 bp downstream, would 
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make a protein of 185 amino acids. Among the two starting sites, the 
second appears more possible since it contains a Kozak sequence 
(GCAGCCAACATG) (20). Comparison of the translated amino acid 
sequence of human GKN1 with that of other species showed homology 
only after the second ATG, and its product is predicted to be of 18 kDa. 
In addition, amino acid sequencing of native GKN1 form pig and N-
terminal Edman’s degradation of native human GKN1 confirmed that the 
protein was made of 185 amino acids containing a 20 amino acids 
extracellular signal peptide localized in the N-terminal region (13-14). 
The protein contains a conserved central structural BRICHOS domain 
(21) of about 100 amino acids containing two conservative cysteine 
residues that are possibly involved in intra- and/or inter-molecular 
disulfide bridges. The putative association of GKN1 with such domain 
structure, and with at least three different possible functions, has been 
proposed, but not yet been conclusively demonstrated. In fact, the 
BRICHOS domain has been found in proteins with a wide range of 
functions and disease associations (22-23). There are 8 known families 
including the cancer associated GKN1, GKN2 and LECT1, the three 
dementia associated ITM2 families, the respiratory disease associated 
proSP-C, and TNMD. Among these protein families there is a little 
sequence identity, the proteins are generally cleaved to produce their 
active forms, and there are no 3D structures in the PDB database even for 
remote homologue proteins. This protein represents a promising tumor 
marker that could be highly useful in early diagnosis and development of 
new drug therapies for GC. 
 
1.3 Scientific hypothesis and aim of the work 
Although GKN1 seems to play an important role in the turnover of 
epithelial cells, in maintaining the integrity of the mucosa and in the 
processes of cell proliferation and differentiation, a full characterization 
of its structure and biological activity is still lacking. The aim of the 
thesis work was to characterize the structural and functional properties of 
GKN1. Since the purification of the protein from human tissues (normal 
human antrum mucosa) resulted very difficult due to the unavailability of 
human specimens, a recombinant production protocol using the 
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homologous expression system of Pichia pastoris was settled. The 
production of a recombinant GKN1 allowed its chemical-physical and 
biochemical characterization by using spectroscopic and biochemical 
techniques. Bioinformatics tools were used for a prediction of a three-
dimensional modelling of the protein. Finally, the recombinant protein 
was also tested for its biological activity in the regulation of cellular 
viability. This recombinant GKN1 could be also useful for crystallization 
trials directed toward the resolution of its 3D structure. 
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MATERIALS AND METHODS  
 
2.1 Microorganisms and culture media 
Escherichia coli (E. coli) JM109 strain was purchased from Boehringer 
and used for genetic manipulation. Culture medium for E. coli was LB 
(Luria-Bertani) liquid and solid (agar), prepared as described by 
Sambrook et al. (24). Pichia pastoris (P. pastoris) GS115 strain was 
purchased from Invitrogen and used as recombinant protein expression 
system. Culture media for P. pastoris were Buffered Minimal Glycerol 
(BMGY, 100 mM potassium phosphate, pH 6.0, 1.34% yeast nitrogen 
base (YNB), 0.002% biotin, 1% glycerol), and Buffered Minimal 
Methanol (BMMY, 100 mM  potassium  phosphate, pH 6.0, 1.34% YNB, 
0.002% biotin, 0.5 % methanol). Ampicillin (Amp) was purchased from 
Sigma and used at a concentration of 1 mg/ml for both bacterial and yeast 
cultures. 
 
2.2 Vector construction and P. pastoris cell transformation 
pCDNA3.1 containing the GKN1 cDNA (pCDNA3.1/GKN1) (14) was 
used as a template for PCR amplification. The following primers were 
used: 
PIC-GKF1 (forward) 5’TACGTAATGAAGTTCACAATTGTCTT3' 
corresponding to M1KFTIVF of full length GKN1; 
PIC-GKF2 (forward) 5’TACGTAAACTATAATATCAACGTCAAT3' 
corresponding to the Y2NYNINVN sequence of mature GKN1 
(truncated of the first 20 leader amino acids); 
PIC-GKR1 (reverse) 5’GCGGCCGCTCAATGGTGATGGTGATG3' 
corresponding to the (His)6 C-terminal region of the pCDNA3.1/GKN1 
construct. 
The first two primers contained SNAB1 restriction sites and the last 
contained NOT1 site, respectively. The PCR (GKN1A and GKN1B) 
products were then cloned in pPIC9K digested with the same restriction 
enzymes, and the isolated positive clones were sequenced 
(pPIC9K/GKN1). 
P. pastoris (strain GS115) competent cells were prepared as it follows: 
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cells were inoculated into 10 ml of Yeast Peptone Dextrose Medium 
(YPD, Invitrogen) and grown overnight at 30 °C in a shaking bath. 
Subsequently, the inoculum was diluted in 100 ml of YPD to a starting 
cell concentration of 0.1 OD660nm. 100 ml of culture were grown at 30 °C 
to a concentration of 0.7 OD660nm. Cell culture was harvested by 
centrifugation at 4500 rpm for 20 min, and washed in 50 ml of solution A 
[1 M sorbitol (Fisher), 10 mM bicine (Sigma), pH 8.35, 3% (v:v) 
ethylene glycol (Merck)]. Cells were re-suspended in 4 ml of solution A, 
and divided into aliquots of 0.2 ml in sterile Eppendorf tubes of 1.5 ml. 
10 ml of DMSO were added in each aliquot. Competent cells were frozen 
at -80 °C. P. pastoris competent cells were transformed according to the 
following procedure. 50 mg of pPIC9K/GKN1, linearized with SAL1, in 
a final volume of 20 ml were used. The DNA was added to competent 
cells still frozen together with salmon sperm (Sigma) as DNA carrier. 
The sample was incubated at 37 °C in a water bath for 5 min under 
shaking. 1.5 ml of solution B [40% (w:v) polyethylene glycol 1000 
(Sigma), bicine 0.2 M, pH 8.35] were added to the samples that were 
incubated for 1 h at 30 °C, centrifuged at 3000 rpm for 10 min and re-
suspended in 1.5 ml of solution C (0.15 m NaCl, 10 mM bicine, pH 
8.35). After a final centrifugation, the pellet was re-suspended in 0.2 ml 
of solution C. The cells were plated on agarose plates containing 
selective His- culture medium (Invitrogen), and grown for 2 days at 30°C. 
 
2.3 GKN1 expression and purification 
Analytical expression was first carried out to identify best expressing 
GKN1 clone. P. pastoris transformed colonies were inoculated into 10 
ml of BMMY. The culture was incubated at 30°C by vigorous shaking 
for 72 h. Cells were then harvested by centrifugation at 3500 rpm for 15 
min at 4 ° C, and the supernatant of each clone was analyzed by SDS-
PAGE electrophoresis and Western blotting using mouse monoclonal 
anti-GKN1 antibody (clone 2E5, Abnova). GKN1A was not expressed. 
In contrast, the mature form of the protein, GKN1B, was expressed in all 
clones examined. The clone showing the high GKN1 expression (clone 
27) was grown, and stored at -80°C. Preparative GKN1 expression was 
performed in 2 l of culture medium. Briefly, 100 ml of P. pastoris clone 
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27 were inoculated in 12 ml of BMGY, and grown overnight at 30°C. 3 
ml of this culture were then used to inoculate 500 ml of BMGY and 
grown overnight up to a cell concentration of 5 OD600nm. Cells were 
harvested by centrifugation, re-suspended in a volume of 2 l of BMMY, 
and grown for 72 h at 30°C under vigorous shaking. After the first 24 h, 
methanol (0.5% final concentration) was added to the growing culture 
every day. Finally, cells were harvested by centrifugation at 8000 rpm for 
40 min, and the resulting supernatant was cleaned using 0.22 mm filters, 
and stored at 4 °C. 
Proteins from supernatant were precipitated with 70% ammonium sulfate 
(844 g/2 l) at 4°C, centrifuged at 13000 rpm for 50 min, and the resulting 
pellet was re-suspended in 50 ml of buffer A (50 mM TrisHCl, pH 8.5). 
The protein sample was then dialyzed against 2 l of buffer A, and applied 
on anion exchange DEAE Sepharose (1x60 cm) (FF, Pharmacia Biotech). 
The column, equilibrated at 4 °C in buffer A, was washed with 10 x 
volumes column, and eluted with a linear gradient (0 - 500 mM NaCl) at 
a flow rate of 2 ml/min (total volume: 10x column volume). The elution 
profile was followed at 280 nm, and fractions (12 ml) were then analyzed 
by SDS-PAGE.  Fractions containing GKN1 were pooled, dialyzed 
against buffer A, and applied on a Ni-NTA Agarose column (10 ml). 
After washing the column with buffer A (10x column volume), the 
column was washed with 5x column volume of buffer A containing 5 
mM imidazole, and subsequently the protein was eluted with buffer A 
containing 100 mM imidazole. Fractions were analyzed by SDS-PAGE 
and Western blotting, and those fractions containing purified GKN1 were 
pooled, dialyzed against buffer A or 20 mM phosphate buffer pH 7.0, and 
stored at –20°C. Protein concentration was determined according to 
Lowry method (25). 
 
2.4 Mass spectrometry 
GKN1 was analyzed on a C8 column by High Performance Liquid 
Chromatography (HPLC) coupled with a LCMS EV 2010 Liquid 
Chromatography Mass Spectrometer (Shimadzu). Sample (30 µl) was 
first eluted at 0.5 ml/min with a liner gradient from 5 to 40% acetonitrile 
(Romil) in water containing 0.1% TFA (trifluoroacetic acid) (Applied 
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Biosystems) in 50 min, and then from 40 to 95% acetonitrile in water 
containing 0.1% TFA, in 20 min. 
 
2.5 Limited proteolysis 
The limited proteolysis experiments were performed on purified GNK1 in 
phosphate buffer at pH 7.0. 100 µg of protein were digested by 10 µg 
trypsin, chymotrypsin in native conditions or denaturing conditions in 
presence of 100 mM DTT (dithiothreitol). The digested products were 
analyzed on denaturing and non-denaturating gels (without boiling the 
protein samples and without adding !-mercaptoethanol) by coomassie 
blue staining. Bands from the gel were then eluted for N-terminal 
sequencing by Edman’s degradation according to a standard procedure. 
 
2.6 Western blotting 
Western blotting was performed according to standard procedure. 
Generally, proteins were separated by SDS–PAGE, electro-transferred to 
PVDF membrane, and incubated for 1 h at room temperature with anti-
GKN1 antibody, at dilution of 1:500. Anti-mouse secondary antibody 
conjugated with horse radish peroxidase (HRP) (Sigma) was used at a 
dilution of 1:20.000. The specific protein was visualized by a enhanced 
chemiluminescence detection reagents (SuperSignal West Pico), and 
exposed to X-ray film. All films were analyzed by using Image J 
software. 
 
2.7 CD and fluorescence spectroscopy 
Sample solutions for spectroscopic measurements were prepared in 20 
mM NaP buffer at pH 8.5, and the protein concentration was determined 
by UV spectra using a theoretical, sequence-based (26), extinction 
coefficient of 30680 M-1 cm-1 at 280 nm. CD spectra were recorded with 
a Jasco J-715 spectropolarimeter  equipped  with a Peltier type 
temperature control system (Model PTC-348WI). Molar ellipticity per 
mean residue, [!] in deg cm2dmol-1, was calculated from the equation: 
[!] = [!]obs mrw/10·l·C, where [!]obs is the ellipticity measured in 
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degrees, mrw is the mean residue molecular weight, (113.3Da) for GKN1 
protein, C is the protein concentration in g/"mL-1 and l is the optical path 
length of the cell in cm. CD spectra were recorded by using 0.1 and 0.5 
cm path length cells in the far-UV and near-UV region, respectively. 
They were recorded at 20°C with a time constant of 4 s, a 2 nm 
bandwidth and a scan rate of 20 nm/min, signal-averaged over at least 
three scans, and baseline corrected by subtracting a buffer spectrum. 
Spectra were analyzed for secondary structure amount according to the 
CDSSTR method (27) using Dichroweb (28-29). The thermal unfolding 
curves were recorded in the temperature mode, by following the change 
of the CD signal at 216nm and at 290nm with a scan rate of 1.0°C/min. 
The temperature-induced denaturation of GKN1 protein was found to be 
irreversible and therefore not allowing us to perform the thermodynamic 
analysis of denaturation curves. 
Fluorescence spectra were recorded at 25°C on a computer assisted Cary 
Eclipse spectrofluorimeter (Varian) at a scan rate of 60 nm/min using an 
excitation wavelength of 280 nm; excitation and emission slits were set 
to 10 nm. The fluorescence spectrum was measured in the range 300-450 
nm. The denaturation with guanidinium chloride (Gdn-HCl) was 
performed using concentrations of 3 M and 6.3 M Gdn-HCl, and then the 
fluorescence spectrum was recorded. 
 
2.8 Cell culture 
Human gastric cancer cell, AGS, human epidermal pulmonary carcinoma 
cell, H1355 and embryonic kidney cell HEK293 lines were grown in 
DMEM-F12 (Dulbecco’s modified Eagle medium, Cambrex) 
supplemented with heat inactivated Fetal Bovine Serum (FBS), 100 U/ml 
penicillin, 100 mg/ml streptomycin, 1% L-glutamine at 37°C in a 5% 
CO2 atmosphere. The cells were harvested by treatment with 0.25% 
trypsin, EDTA 0.02M in PBS pH 7.2, washed with culture medium and 
re-suspended in complete growth medium. The cells were maintained in 
culture for no more than two weeks. 
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2.9 Cell viability assay 
Cell proliferation was assessed by measuring the reduction of 3- (4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) to 
formazan salts by the enzyme succinate dehydrogenase. 
In this colorimetric assay, the activity of mitochondrial succinate 
dehydrogenase, active only in living cells, which cuts the tetrazole ring of 
MTT (yellow substance) with the formation of formazan (a blue salt) is 
measured. This reaction is evaluated by spectrophotometric reading of 
the sample at a wavelength of 570 nm. Re-suspended cells (about 7500 
cells/well) were plated in 96-well plates and exposed to increasing 
concentrations of GKN1 (10-4, 10-5, 10-6, 10-7 M) for different time 
intervals (24, 48 and 72 h). Subsequently, the MTT solution (5 mg/ml) in 
PBS was added to the wells, and the plates were incubated for 2 h at 
37°C. The reaction was stopped by removing the supernatant followed by 
the dissolution of the formazan product by the addition of 150 ml of 
isopropanol. The absorbance at 570 nm was determined using a Bio-Rad 
ELISA reader. Cell proliferation was expressed as the percentage of 
formazan formation in the samples treated with the substances compared 
to the negative control treated with only solvent. 
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RESULTS 
3.1 Expression and purification of recombinant GKN1 
P. pastoris expression vector pPIK9K, methanol inducible, containing 
GKN1 cDNA encoding mature protein was used to transform GS115 
yeast strain. The expressed recombinant GKN1 protein, secreted into 
culture medium, was identified after ammonium sulfate precipitation 
(70%) by mass spectrometry coupled to HPLC. As reported in Fig. 1A, 
HPLC chromatogram showed a peak of GKN1 accounting of about 2% 
of total proteins. The peak was collected, and the presence of GKN1 was 
confirmed by electrospray mass spectrometry analysis. Following 
ammonium sulfate precipitation, GKN1 was further purified by DEAE 
and Ni-NTA chromatography. Fig. 1B shows the DEAE chromatogram 
of GKN1 eluted with a linear salt gradient. Fractions containing the 
recombinant protein were analyzed by SDS-PAGE (Fig. 1C), and the 
appropriate pooled fractions were separated on Ni-NTA agarose 
chromatography. The Ni-NTA elution profile is reported in Fig. 1D. 
Finally, the purified protein was concentrated up to about 2-3 mg/ml and 
stored in 20 mM phosphate buffer, pH 7.4 at –20°C. Fig. 1E reports 
SDS-PAGE electrophoretic profile of the purified GKN1. The total 
amount of GKN1 purified from 1 liler of culture medium was around 40 
mg as evaluated by Lowry method. 
 
3.2 Primary structure and proteolytic sites of recombinant GKN1 
Purified GKN1 was analyzed by limited proteolysis using trypsin, 
chymotrypsin and thermolysin proteases. From the SDS-PAGE 
electrophoretic profile of the time course of time-dependent trypsin 
cleavage of GKN1 two major fragments of about 17 and 11 kDa were 
detected (Figure 2A). The formation of proteolytic products was 
accompanied by the disappearance of intact recombinant GKN1 (Fig. 
2B). Edman’s degradation of the largest protein fragment (17 kDa) 
allowed to establish the N-terminal sequence of the intact protein thus 
indicating the presence of a proteolytic cleavage site toward the C-
terminal, whereas the sequence of 11 kDa fragment showed the presence 
of a proteolytic site at the level of Lys91 (numbering mature GKN1). 
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Figure 1 Purification of GKN1 
A. HPLC of culture medium. B. DEAE chromatography after ammonium 
sulphate precipitation. C. SDS-PAGE of DEAE fraction containing 
GKN1. D. SDS-PAGE of Ni-NTA chromatography elution profile of the 
pool after DEAE fractions. E. SDS-PAGE of the purified GKN1 
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Figure 2 Proteolysis of GKN1 with trypsin 
A. GKN1 was incubated in the presence of trypsin and at the indicated 
times, sample aliquots were withdrown from the reaction mixture and 
separated on SDS-PAGE. Lanes: 1 – 8 samples after 1.5, 3.0, 4.5, 6.0, 
7.5, 9.0, 10.5, 12.0 minutes incubation; SM, size marker; C, control intact 
GKN1. B. Densitometric evaluation of the band intensity. 
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Limited proteolysis of the protein with chymotrypsin yielded the 
formation of three major peptides of about 15, 10 and 5 kDa (Fig. 3). The 
N-terminal sequence of the 15 kDa fragment started at level of Tyr4 
therefore, there must be a further proteolitic cleavage site at the C-
terminal region of the protein. 
The N-terminal sequence of the 10 kDa fragment indicated the presence 
of a cleavage site at level of Phe141. Also in this case the molecular 
weight of this fragment suggests the presence of an additional cleavage 
site at the C-terminal. The third 5 kDa fragment gave two different N-
terminal sequences indicating the presence of two proteolytic sites at 
levels of His66 and Tyr103. Also for these two fragments, their sizes 
suggests the presence of an additional cleavage site at the C-terminal. 
Following the digestion of GKN1 with thermolysin, four fragments of 
about 18, 16, 11 and 9 kDa were observed by SDS-PAGE (Fig. 4A). The 
first two fragments showed the same N-terminal sequences indicating that 
both fragments were obtained by cleavage of GKN1 at position of Asn5 
and at two different cleavage positions in the C-terminal region of the 
protein. The fragment of 11 kDa produced two N-terminal sequences that 
indicated cuts at level of Lys87 and Phe141. On the bases of the sizes of 
these two fragments, the presence of an additional cleavage site at the C-
terminal was supposed. From the 9 kDa band three fragments were 
generated corresponding to cleavages at level of Lys87, Phe141 and 
Phe142. Also in this case, additional cleavage sites are present at the C-
terminal region of each fragment. 
To assess the region of GKN1 that is recognised by GKN1 antibody, the 
protein was cleaved by proteases and the digestion products were 
analyzed by Western blotting. When trypsin and chymotrypsin were used, 
the antibody recognized the largest proteolytic fragment whereas it 
recognized the 16 kDa fragment of thermolysin digestion (Fig. 5). These 
results suggested that the epitopic region of the protein recognized by the 
mouse monoclonal antibody anti-GKN1 is located within the first 60 
amino acid residues of the protein. A schematic representation of the 
recombinant GKN1 primary structure and of proteolytic sites is reported 
in Fig. 6. 
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Figure 3 Proteolysis of GKN1 with chymotrypsin 
A. GKN1 was incubated in the presence of chymotrypsin and at the 
indicated times, sample aliquots were withdrown from the reaction 
mixture and separated on SDS-PAGE. Lanes: C, control intact GKN1; 1 – 
5 samples after 5, 10, 15, 20, 25 minutes incubation; SM, size marker. B. 
Densitometric evaluation of the band intensity. 
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Figure 4 Proteolysis of GKN1 with thermolysin 
A. GKN1 was incubated in the presence of thermolysin and at the 
indicated times, sample aliquots were withdrown from the reaction 
mixture and separated on SDS-PAGE. Lanes: SM, size marker; 1 – 3 
samples after 5, 10, 15 minutes icubation; C, control intact GKN1. B. 
Densitometric evaluation of the band intensity. 
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Figure 5 Western blot of GKN1 proteolysis with trypsin, 
chymotrypsin and thermolysin 
C, control intact GKN1. Lane 1, 2 and 3 GKN1 after digestion with 
trypsin, chymotrypsin and thermolysin, respectively. 
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Figure 6 Schematic representation of GKN1 proteolytic sites 
A. Amino acid sequence of recombinant His tagged GKN1 showing the 
region containing the BRICHOS domain. B. Schematic representation of 
proteolytic sites. Chm, Chymotrypsin; trm, Thermolysin; trp, Trypsin.  
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From these results emerged that a trypsin proteolytic site was located at 
the level of Lys91 in a region of the protein comprised between the first 
Cys (Cys63) and the other three Cys (Cys124, Cys147 and Cys161). To 
test whether these two cysteines were involved in a disulfide bond in the 
folded protein, performed a trypsin digestion in both reducing and non-
reducing conditions. The digestion products were then separated on a 
SDS-PAGE in non-reducing condition. The results reported in Fig. 7 
showed that in presence of 1 mM DTT, GKN1 trypsin digested gave rise 
to two proteolytic products (17 and 11 kDa), whereas in absence of DTT 
it produced a band with the same molecular weight of undigested protein. 
These data indicated that the two proteolytic fragments were bound by a 
disulfide bond between Cys63 and one of the other three cysteine 
residues. 
 
3.3 Fluorescence measurements 
With the aim at investigatis the stability of recombinant GKN1, toward 
chemical denaturants, protein fluorescence spectra were acquired either in 
the presence or in the absence of chemical denaturats. In general, 
wavelength of the maximum fluorescence intensity of aromatic residues 
has tendency to shift toward long wavelengths, when the aromatic 
residues  present in hydrophobic regions become non  exposed to polar 
environments. The results obtained  reported in Fig. 8 and Fig. 9 indicated 
that GKN1 in the absence of denaturants showed a typical maximum 
fluorescence intensity at around 340 nm, characteristic of rather solvated 
aromatic residues. The addition of increasing concentration of Gdn-HCl 
promoted a quencing of the fluorescence intensity and a concomitant 
marked red shift of the maximum fluorescence. 
The chemical denaturation  profiles  (Fig. 8B) evaluated either as 
variation of maximum fluorescence intensity at 343nm or shift of 
wavelength of the maximum fluorescence intensity at 343nm showed that 
the value of the denaturant concentration at half completion of the 
transition was 2.4 M for both 
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Figure 7 Proteolysis of GKN1 in absence and presence of DTT 
GKN1 was incubated in the presence of trypsin and at the indicated times, 
sample aliquots were withdrawn from the reaction mixture and separated 
on non-denaturing SDS-PAGE. Lanes: 1-3, sample after 5, 10 and 15 
minutes incubation in absence of DTT; 4 – 6, sample after 5, 10 and 15 
minutes incubation in presence of DTT. SM, size marker 
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Figure 8 Denaturation profile of GKN1 in guanidine-HCl 
A. Fluorescent emission spectra of GKN1 at increasing concentration of 
Gdn-HCl. The exciting wavelength was 280nm. The emission and 
excitation slits were set at 10nm. B.Variation of the maximum 
fluorescence intensity at 343 nm (!) and shift of the maximum 
fluorescence intensity  (•) at increasing concentrations of Gdn-HCl. 
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Figure 9 Denaturation profile of GKN1 in urea 
A. Fluorescent emission spectra of GKN1 at increasing concentration of 
urea. The exciting wavelength was 280nm. The emission and excitation 
slits  were set at 10nm. B. Variation of the maximum fluorescence 
intensity at 343 nm (!) and shift of the maximum fluorescence intensity  
(•) at increasing concentrations  of urea. 
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The behavior of the protein against urea denaturation was different. In 
fact, the fluorescence spectra of GKN1 at increasing concentration of urea  
showed only a small shift of the maximum fluorescence intensity and a 
concomitant progressive increase of fluorescence intensity (Fig. 9A). The 
value of the urea concentration at half completion of the transition was 
3.8 M (Fig. 9B). 
To evaluate the behavior of the protein in non-denaturing conditions, 
temperature melting profiles were recorded by fluorescences 
mesearuments. The heat denaturation profile at pH 6.5 showed a t1/2 of 
70°C (Fig. 10A).  However, the profile registred at different pH, indicated 
that the heat denaturation was pH – dependent. In fact,  in the pH 5-8 
interval, t1/2 increased as the pH increased (Fig.10B). 
 
3.4 Circular dichroism measurements 
Secondary structure of recombinant GKN1 was investigated by means of 
CD in the far-UV region. Figure 11A shows the CD spectra of the intact 
GKN1 recorded in  20 mM phosphate buffer pH 8.5. The spectra recorded 
at 20°C shows an intense negative band below 240 nm that is indicative 
of a prominent content of " structure. From the analysis of the CD spectra 
with CDSSTR method the percentage of secondary structure found in 
recombinant GKN1 was calculated. As reported in Table 1, the helix, 
strand, turns and unordered structure were 15, 29, 23, and 33%, 
respectively. In addition, the difference between the experimental and 
reconstructed data of the CD spectra was negligible. From these data it 
emerges that GKN1 contain a higher percentage of "-strands with respect 
the #-helix content. 
 
Table 1 Calculated Secondary Structure Fractions in GKN1 
Helix1 Helix2 Strand1 Strand2 Turns Unordered 
0.06 0.09 0.18 0.11 0.23 0.33 
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Figure 10 Denaturation profile of GKN1 in non-denaturing 
conditions 
A. Temperature melting profile of GKN1 at pH 6.5 evaluated as 
percentage of fluorescence decrease at 340 nm. The exciting wavelength 
was 280nm. The  emission and excitation slits  were set at 10nm . The 
scan-rate was 0.2°C /min. B. Temperature melting  (t1/2) evaluated at 
different pH. 
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Figure 11 CD spectra of GKN1 in the far UV 
A. CD spectra of native GKN1 at 20 °C, pH 8.5. B. CD spectra at 20°C 
(•) and 100 °C (!) . C. Variation of molecular ellipticity with 
temperature. D. First derivative of thermal denaturation profile of 
molecular ellipticity. 
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The CD profile taken at 100°C (Fig. 11B) shows the occurring of a 
transition in fact, a large band with a minimum around 200 nm is present 
thus indicating the formation of random coil structures. However, the CD 
profile still shows the presence of a rather large band above 200 nm thus 
indicating still the presence of residual secondary structure that could be 
due to the formation of soluble aggregates following thermal 
denaturation. To evaluate the thermal stability of the protein, CD 
denaturation curves were recorded in the temperature range 20 – 100 °C. 
The denaturation profile (Fig 11C) was obtained measuring the molecular 
ellipticity at 216 nm, corresponding to disappearance of helix content. 
The profile shows a flex around 59,5°C however, because the flex is not 
very sharp, the profile might suggest that the denaturation process occurs 
through several steps. In fact, the first derivative of the denaturation 
profile (Fig. 11D) indicated a major denaturation transition at 59.5°C and 
the presence of an additional transition at a lower temperature (47.5 °C). 
This transition appears irreversible because the CD spectra recorded at 
20°C after thermal denaturation is not coincident to that recorded in the 
native condition (Fig. 11B). 
Analysis of CD spectra in the near-UV region, recorded at 20°C and at 
100°C are reported in Fig. 12A. The spectra at 20°C shows a more sharp 
band at 290 nm and a large band at 270 nm. The presence in this spectral 
region of these defined bands were indicative of a well defined ternary 
structure of the recombinant GKN1. However, both bands disappeared 
when the spectra were recorded at 100°C. This behaviour clearly 
indicated that at 100°C the tertiary structure of the protein is completely 
lost. The near-UV denaturation profile evaluated at 290 nm in the 
temperature interval 10-100°C (Fig. 12B) indicated the presence of two 
transition events, one occurring around 55°C and a second one at 77°C. 
These data suggest that the protein is endowed of two distinct domains 
that follow an independent thermal denaturation process. 
Evaluation of the calorimetric properties of GKN1 was determined in 20 
mM phosphate buffer pH 8.5 by differential scanning calorimetry (DSC) 
and the results obtained (Fig. 13) were similar to those obtained from 
near-UV. In fact, the DSC profile is quite broad showing a pick around 
59.5°C and a large shoulder around 75°C. 
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 Figure 12 CD spectra of GKN1 in the near UV 
 A. CD spectra  of native GKN1 at 20 °C, pH 8.5 (•) and of GKN1 at 
 100 °C (!) . B. Variation of molecular ellipticity with temperature.  
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    Figure 13 Differential scanning calorimetry (DSC) of GKN1 
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3.5 GKN1 secondary structure prediction and 3D modelling 
Bioinformatic tools to predict the secondary structure of recombinant 
GKN1 were used to estabilish whether it would closer to that determined 
by CD spectroscopy. To this purpose, the amino acid sequence of the 
expressed protein (Fig. 6A) was used as template. Psipred Server 
generated a scheme (Fig. 14) showing the distribution of secondary 
structural elements within GKN1 sequence from which it was calculated 
that the content of #-helics and "-sheet was 13.9 and 29.6%, respectively, 
values very close to those obtained by CD spectroscopy (see Table 1). 
Furthermore, using the same sequence, a 3D model of GKN1 was 
generated through Tasser Bioinformatic Server. A 3D model of GKN1 
was predicted on the basis of known structure of proteins showing 
segments of their sequence with a similar secondary structural 
arrangement. Five possible pdb model files were generated with a C-score 
higher than –5.2. Among these models the one with C-score of – 4.34 was 
chosen as possible GKN1 3D model (Fig. 15) because its content of #-
helix and "-sheet was closer to those represented in Fig. 14. 
 
3.6 Biological activity of GKN1 
The data above reported clearly indicated that recombinant GKN1 was 
characterized by the presence of both secondary and ternary structure, 
thus suggesting at least a correct folding of the protein. Because GKN1 
has been reported to affect cell viability, to assess if recombinant GKN1 
was also biologically active, the ability to affect cell proliferation in vivo 
using different cell cultures at different dosage of GKN1 was evaluated. 
The results (Fig. 16A) showed that GKN1 was endowed by anti-
proliferation effect at a concentration of 0.5 µM already after 24 hours of 
treatment of a human gastric carcinoma (AGS) and a human lung 
epidermid cancer (HI355) cell lines. The effect was dependent by the 
concentration of the protein since the inhibition of cell growth was higher 
at higher GKN1 concentration. A less marked effect was instead observed 
using human embrypnic kidney 293 (HEK 293)  cell line (Fig. 16B). 
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Figure 14 Secondary structure of GKN1 predicted by Psipred        
Server 
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Figure 15 3D model of GKN1 built at the Tasser Bioinformatic 
Server. The position of the exposed Lys 91 and of the two closer 
cysteines  or shown 
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Figure 16 Effect of GKN1 on cell growth 
A. AGS cell growth in absence (•) or in presence of 0.5 µM (!) and 3 
µM (!) GKN1. B. H1355 cell growth in absence (•) or in presence of 0.5 
µM (!) and 3 µM (!) GKN1. C. HEK293 cell growth in absence (•) or 
in presence of 5.5 µM (!), 11 µM (!) and 18 µM (!) GKN1. 
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DISCUSSION/CONCLUSIONS 
In this study, the structural and biochemical properties of recombinant 
human GKN1 produced in yeast Pichia pastoris were investigated. The 
use of yeast system for protein expression was suggested by previous 
experiments where the expression of the GKN1 in heterologous 
Escherichia coli always gave a product that accumulated into inclusion 
bodies, even if the expression was carried out at 15°C (data not shown). 
All the attempts to refold the protein from inclusion bodies were 
unsuccessful. By contrast, the expression of GKN1 in yeast allowed 
obtaining purified soluble GKN1 at high yield. 
The finding that the protein produced in yeast was soluble in water 
suggested that recombinant GKN1 possesses a certain level of structural 
organization. To investigate the structural features of the protein, its 
biochemical and spectroscopic properties were analyzed. Limited 
proteolysis indicated that the protein was moderately resistant toward 
proteases. In fact, time-course reactions with three proteases (trypsin, 
chimotrypsin and thermolysin) showed only a partial degradation of the 
protein. Protease resistance was also reported for GKN1 purified from 
chicken gizzard smooth muscle (21). However, in the latter case, the 
protein was cleaved by trypsin only at its N-terminal giving rise to a 18 
kDa resistant core protein, in agreement to evidence that some proteins 
containing the BRICHOS domain are similarly cleaved (22-23). Because 
GKN1 is highly expressed in human normal stomach mucosal antrum, 
and thus exposed to a harsh environment, characterized by low pH and 
the presence of proteolytic enzymes (pepsin), its stability against enzyme 
degradation is highly required. 
Moreover, the protein appears to be stabilized by the presence of a 
disulfide bridge most likely occurring between Cys63 and one of the other 
three Cys (Cys124, Cys147 and Cys161). No finding is reported up to 
now concerning the involvement of GKN1 cysteines in the interaction 
with other partner proteins, as instead it occurs between the homologous 
human GKN2 and TFF1 bounded through a disulfide bridge (30). 
However, GKN2 contains an additional cysteine residue (with respect to 
GKN1) that could be involved in this interaction (31). 
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The fluorescence properties of native GKN1 showed a #max fluorescence 
intensity at 340 nm which is characteristic of proteins with non tight 
globular structure. Generally globular proteins show fluorescence #max at 
a wavelength below 335 nm (32). The fluorescence spectra in the 
presence of guanidine suggested that recombinant GKN1 was correctly 
folded because a  red shift was  observed upon the addition a Gdn-HCl; 
This finding was indicative of a progressive exposure of aromatic amino 
acid residues. In addition, since increasing intensity of the fluorescence 
emission was observed only at Gdn-HCl concentration higher than 2.4 M, 
we supposed that the denaturation pathway of GKN1 occurs through the 
formation of an intermediate state. The fluorescence spectra acquired at 
increasing concentrations of urea showed a very small red shift with  a 
continuous increasing of the fluorescence  intensity, thus suggesting that 
the structure of GKN1 does not possess a hydrophobic globular core. 
Moreover, the differences of GKN1 fluorescence profiles in Gdn-HCl and 
urea suggested that the protein was more stabilized by electrostatic 
interactions rather than hydrophobic ones. Thus, the ionic nature of Gdn-
HCl masks electrostatic interactions in GKN1, a phenomenon that was 
absent when the uncharged urea was used.  Although the difference in the 
ionic character should be the relevant factor in the denaturation process, 
the stability of GKN1 against Gdn-HCl suggests that the contribution of 
salt bridges to its stability may be limited. In this case, the fluorescence 
transition curves indicated that [urea]1/2 /[Gdn-HCl] 1/2 was about two 
suggesting that Gdn-HCl has a stronger denaturing activity against 
GKN1. In conclusion, these results suggested a different unfolding 
pathways and mechanisms for the two denaturants. The following scheme 
(Fig. 17) represents the two possible unfolding pathways in Gdn-HCl and 
urea solutions for human recombinant GKN1. ( 33). The results from CD 
spectroscopy highlighted that GKN1 has a content of !-structures higher 
than $-helix, and only 33% of the protein contains random coils. 
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Figure 17 Schematic representation of the two possible unfolding 
pathways in Gdn-HCl and urea solutions for human GKN1 
 
 
 
 
 
 
 
 
 
 
 
Native (N) Non-Native
Gdn-HCl 2 M                     
GKN1 Intermediate state (I)
Denatured state (D)
Urea 8M Gdn-HCl 6M
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These structural data are in agreement with predictions of secondary 
structure made for proteins containing the BRICHOS domain, and in 
particular with that of gastrokine family (34). 
Most BRICHOS proteins have four regions: hydrophobic, linker, 
BRICHOS and C-terminal domains. The hydrophobic region is often a 
trans-membrane segment (predictions and 35) included in the signal 
peptide for GKN1 and GKN2 (36) . GKN1 and GKN2 may have a central 
natively disordered segment corresponding with a strongly predicted 
coiled segment. This was surprising since this characteristic was not 
shared by the others BRICHOS-protein family (34).  
A prediction of the secondary structure of GKN1 made by the PSIPRED 
Protein Structure Prediction Server showed that it was consistent with the 
secondary structure predicted on the basis of CD spectroscopy (Fig. 14). 
In fact, the content of !-sheet and $-helix was 33.3%, 14.5%, 
respectively, and such values are very similar to those predicted by the 
analysis of the CD spectra of the native protein. In particular, the CD 
profile is quite similar to that of "I-proteins showing a positive band 
around 190 nm with a negative shoulder around 220 nm (29). 
Furthermore, the CD melting profiles in the far and near- UV as well as in 
DSC measurement indicated that the protein was most likely 
characterized by the presence of two structural domains: one domain was 
more sensitive to physical and chemical denaturation and another one 
more resistant to denaturation, these domains corresponding, respectively, 
to the lower and higher DSC transitions. 
Finally, with the purpose to construct a possible tertiary model structure 
of the recombinant GKN1, the bioinformatic program offered by the 
Tasser Server (Center for Computational Medicine and Bioinformatics, 
University of Michigan) was used. The model obtained predicted the 
structure of GKN1 on the base of sequence alignments with proteins of 
known 3D structure showing sequence similarity in small regions of the 
protein (Fig.15). The model is coherent with the content of !-sheet and $-
helix predicted by PSIPRED Protein Structure Prediction Server. From 
this model it is possible to highlight that at least Cys61 is close to Cys157 
justifying the experimentally predicted disulfide bridge. Furthermore, the 
model clearly shows that the Lys 91 is very accessible to trypsin cleavage  
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in agreement to the proteolytic results. Moreover, the 3D model of GKN1 
is in agreement with the spectroscopic data suggesting the presence of 
two distinct domains in the protein. The recombinant GKN1 showed also 
an antiproliferative effect an cancer cell lines. This result confirmes the 
proposed protection role of GKN1 toward early gastric mucosal 
inflammation an support also the postulated role as tumor suppressor.  
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